Canadian Society of Cardiac Surgeons (CSCS)

Cardiac Surgery

311 - VALVULAR HEART DISEASE: MAKING SENSE OF A CHANGING LANDSCAPE AND EVOLVING GUIDELINES

Co-Chair(s)

• RN

  Rashmi Nedadur
• 

  Christopher White, MD PhD (he/him/his)

  Cardiac Surgeon
  CSCS
  Dalhousie University

Panelist(s)

• RC

  Renzo Cecere, MD, FRCSC

  Principal Investigator

Presenter(s)

• 

  Gianluigi Bisleri, MD

  Associate Professor of Surgery
  University of Toronto
  University of Toronto

Special Invited Guest(s)

• MB

  Michael Borger

Presenter(s)

• WK

  William Kent, MD MSc FRCSC

  Cardiac Surgeon
  University of Calgary

Special Invited Guest(s)

• PM

  Patrick Myers

Presenter(s)

• 

  Christopher White, MD PhD (he/him/his)

  Cardiac Surgeon
  CSCS
  Dalhousie University

Contact/Moderator(s)

• SS

  Shaina Scrimgeour

Session Description: Valvular heart disease is undergoing a rapid transformation, driven by evolving evidence, updated guidelines, and expanding interventional options. This session brings together international thought leaders to distill the most critical updates from the 2025 guidelines and highlight key clinical trials reshaping the management of structural valve disease. A moderated panel will explore the implications for surgical practice and heart team collaboration in this dynamic landscape.

Presentations:

1. What’s New and What Matters: 2025 Valvular Heart Disease Guideline Updates for Every Clinician – Dr. Michael Borger


2. Structural Valve Disease: Interventions and Trials – A Year in Review – Dr. Patrick Myers